These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 11904759)
1. Involvement of Fas/Fas ligand system in the spinal cords of HTLV-I-associated myelopathy. Umehara F; Itoh K; Michizono K; Abe M; Izumo S; Osame M Acta Neuropathol; 2002 Apr; 103(4):384-90. PubMed ID: 11904759 [TBL] [Abstract][Full Text] [Related]
2. Expression of Fas ligand in patients with evident skull base involvement of nasopharyngeal carcinoma. Tsai MH; Chow KC; Lin TY; Yeh SP; Hsueh CT; Chi KH Oncol Rep; 2002; 9(2):247-51. PubMed ID: 11836588 [TBL] [Abstract][Full Text] [Related]
3. Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients. Hamzaoui A; Ammar J; Graïri H; Hamzaoui K Mediators Inflamm; 2003 Aug; 12(4):209-14. PubMed ID: 14514471 [TBL] [Abstract][Full Text] [Related]
4. Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure. Mita A; Hashikura Y; Tagawa Y; Nakayama J; Kawakubo M; Miyagawa S Am J Gastroenterol; 2005 Nov; 100(11):2551-9. PubMed ID: 16279913 [TBL] [Abstract][Full Text] [Related]
5. Fas ligand is up-regulated during the colorectal adenoma-carcinoma sequence. Belluco C; Esposito G; Bertorelle R; Alaggio R; Giacomelli L; Bianchi LC; Nitti D; Lise M Eur J Surg Oncol; 2002 Mar; 28(2):120-5. PubMed ID: 11884046 [TBL] [Abstract][Full Text] [Related]
6. Detection of Fas ligand in the bovine oviduct. Bergqvist AS; Killian G; Erikson D; Hoshino Y; Båge R; Sato E; Rodríguez-Martínez H Anim Reprod Sci; 2005 Mar; 86(1-2):71-88. PubMed ID: 15721660 [TBL] [Abstract][Full Text] [Related]
7. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas. Shukuwa T; Katayama I; Koji T Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912 [TBL] [Abstract][Full Text] [Related]
8. [Analysis of HAM rat disease with HTLV-I infection, an animal model for HAM/TSP in human-immunohistochemical, immuno-electron microscopic and flow cytometrical analyses of microglia/macrophages in the affected spinal cord]. Morita K Hokkaido Igaku Zasshi; 1998 May; 73(3):253-74. PubMed ID: 9719951 [TBL] [Abstract][Full Text] [Related]
9. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations. Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989 [TBL] [Abstract][Full Text] [Related]
10. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption. Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769 [TBL] [Abstract][Full Text] [Related]
11. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Huerta-Yepez S; Vega M; Garban H; Bonavida B Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892 [TBL] [Abstract][Full Text] [Related]
12. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma. Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844 [TBL] [Abstract][Full Text] [Related]
14. Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: how the immune system starts its second century. Pinti M; Troiano L; Nasi M; Bellodi C; Ferraresi R; Mussi C; Salvioli G; Cossarizza A Circulation; 2004 Nov; 110(19):3108-14. PubMed ID: 15505087 [TBL] [Abstract][Full Text] [Related]
15. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908 [TBL] [Abstract][Full Text] [Related]
16. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma. Satchell AC; Barnetson RS; Halliday GM Br J Dermatol; 2004 Jul; 151(1):42-9. PubMed ID: 15270871 [TBL] [Abstract][Full Text] [Related]
17. The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma. Ogawa S; Nagao M; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Nakajima Y Anticancer Res; 2004; 24(3a):1569-79. PubMed ID: 15274324 [TBL] [Abstract][Full Text] [Related]
18. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas. Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244 [TBL] [Abstract][Full Text] [Related]
19. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy. Pongcharoen S; Searle RF; Bulmer JN Placenta; 2004 Apr; 25(4):321-30. PubMed ID: 15028424 [TBL] [Abstract][Full Text] [Related]
20. Involvement of the Fas-Fas ligand system and active caspase-3 in abnormal apoptosis in human testes with maturation arrest and Sertoli cell-only syndrome. Kim SK; Yoon YD; Park YS; Seo JT; Kim JH Fertil Steril; 2007 Mar; 87(3):547-53. PubMed ID: 17123522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]